Calcium channel blockers: effect on morphine-induced hypermotility

[1]  P. Skolnick,et al.  The behavioral effects of the calcium agonist BAY K 8644 in the mouse: Antagonism by the calcium antagonist nifedipine , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  V. Libri,et al.  Tripelennamine enhances buprenorphine-, but not pentazocine-induced hyperactivity in mice , 2004, Psychopharmacology.

[3]  G. Chiara,et al.  Dopaminergic D-1 receptors: essential role in morphine-induced hypermotility , 2004, Psychopharmacology.

[4]  B. D'udine,et al.  Antihistaminics enhance morphine-, but not amphetamine-and scopolamine-induced hyperactivity in mice , 2004, Psychopharmacology.

[5]  F. Hoffmeister,et al.  Calcium agonists and antagonists of the dihydropyridine type: Antinociceptive effects, interference with opiate-μ-receptor agonists and neuropharmacological actions in rodents , 2004, Psychopharmacology.

[6]  A. Oliverio,et al.  Genotype-dependent sensitivity and tolerance to morphine and heroin: Dissociation between opiate-induced running and analgesia in the mouse , 2004, Psychopharmacologia.

[7]  Kinzo Matsumoto,et al.  Decrease in analgesic effect of nifedipine following chronic morphine administration. , 1988, European journal of pharmacology.

[8]  E. Contreras,et al.  Calcium channel antagonists increase morphine-induced analgesia and antagonize morphine tolerance. , 1988, European journal of pharmacology.

[9]  J. Cadet,et al.  The iminodipropionitrile (IDPN)-induced dyskinetic syndrome in mice: Antagonism by the calcium channel antagonist nifedipine , 1988, Pharmacology Biochemistry and Behavior.

[10]  V. Ramkumar,et al.  Prolonged morphine treatment increases rat brain dihydropyridine binding sites: possible involvement in development of morphine dependence. , 1988, European journal of pharmacology.

[11]  M. Kavaliers.  Calcium channel blockers inhibit the antagonistic effects of PheMetArgPhe-amide (FMRFamide) on morphine- and stress-induced analgesia in mice , 1987, Brain Research.

[12]  R. Squires,et al.  Non-stereospecific excitatory actions of morphine may be due to GABA-A receptor blockade. , 1987, European journal of pharmacology.

[13]  E. Esposito,et al.  Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats. , 1987, European journal of pharmacology.

[14]  M. Kavaliers.  Stimulatory influences of calcium channel antagonists on stress-induced opioid analgesia and locomotor activity , 1987, Brain Research.

[15]  J. Grebb.  Nifedipine and flunarizine block amphetamine-induced behavioral stimulation in mice. , 1986, Life sciences.

[16]  W. Freed,et al.  Differences between calcium channel inhibitors in their effects on phencyclidine-induced behavioral stimulation in mice , 1985, Pharmacology Biochemistry and Behavior.

[17]  D. Middlemiss,et al.  A functional correlate for the dihydropyridine binding site in rat brain , 1985, Nature.

[18]  M. Szikszay,et al.  Potentiation of thermoregulatory and analgesic effects of morphine by calcium antagonists. , 1984, Pharmacological research communications.

[19]  Ross Dh,et al.  Nerve cell calcium as a messenger for opiate and endorphin actions. , 1979 .

[20]  D. Ross,et al.  Nerve cell calcium as a messenger for opiate and endorphin actions. , 1979, Advances in biochemical psychopharmacology.

[21]  R. Harris,et al.  Effects of acute and chronic morphine treatments on calcium localization and binding in brain. , 1978, The Journal of pharmacology and experimental therapeutics.

[22]  K. Rice,et al.  Stereospecific and nonstereospecific effects of (+)- and (-)-morphine: evidence for a new class of receptors? , 1977, Science.